Stay updated on Suprachoroidal CLS-AX Safety in AMD Clinical Trial
Sign up to get notified when there's something new on the Suprachoroidal CLS-AX Safety in AMD Clinical Trial page.

Latest updates to the Suprachoroidal CLS-AX Safety in AMD Clinical Trial page
- Check2 days agoChange DetectedThe OASIS study record for CLS-AX in neovascular age-related macular degeneration is available, with its trial details, results, eligibility requirements, participating locations, and study documents.SummaryDifference56%

- Check8 days agoChange DetectedThe site revision identifier changes from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check15 days agoChange DetectedA banner announces NIH website transition updates and says federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check22 days agoChange DetectedThe site footer revision marker changes from v3.7.1 to v3.7.2 on the access-denied page.SummaryDifference0.2%

- Check29 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check50 days agoChange DetectedThe study page now shows a 403 Forbidden error, blocking access to the study record. The previous content is replaced by an access-denied screen.SummaryDifference19%

Stay in the know with updates to Suprachoroidal CLS-AX Safety in AMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Suprachoroidal CLS-AX Safety in AMD Clinical Trial page.